Interactive Financial Charts Not Available

Elanco Animal Health (ELAN) | Financial Analysis & Statements

Elanco Animal Health Inc. | Mid-cap | Healthcare

$20.47

-1.59%

| Elanco Animal Health Stock Comparison:

Elanco Animal Health vs Haleon Plc - ADR Elanco Animal Health vs United Therapeutics Elanco Animal Health vs Regencell Bioscience Elanco Animal Health vs Alkermes plc Elanco Animal Health vs Prestige Consumer Elanco Animal Health vs S&P 500 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 1.2B

Gross Profit 713.0M 57.45%

Operating Income 85.0M 6.85%

Net Income 11.0M 0.89%

EPS (Diluted) $0.02

Balance Sheet Metrics

Total Assets 13.7B

Total Liabilities 7.0B

Shareholders Equity 6.8B

Debt to Equity 1.03

Cash Flow Metrics

Operating Cash Flow 185.0M

Free Cash Flow 180.0M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Elanco Animal Health Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue i	4.4B	4.4B	4.4B	4.8B	3.3B
Cost of Goods Sold i	2.0B	1.9B	1.9B	2.1B	1.7B
Gross Profit i	2.4B	2.5B	2.5B	2.6B	1.6B
Gross Margin % i	54.9%	56.3%	56.6%	55.2%	49.0%
Operating Expenses
Research & Development i	344.0M	327.0M	321.0M	369.0M	329.0M
Selling, General & Administrative i	1.3B	1.3B	1.3B	1.4B	997.0M
Other Operating Expenses i	-	-	-	-	-
Total Operating Expenses i	1.7B	1.6B	1.6B	1.8B	1.3B
Operating Income i	251.0M	326.0M	384.0M	304.0M	-82.0M
Operating Margin % i	5.7%	7.4%	8.7%	6.4%	-2.5%
Non-Operating Items
Interest Income i	-	-	-	-	-
Interest Expense i	235.0M	277.0M	241.0M	236.0M	150.0M
Other Non-Operating Income	472.0M	-1.2B	-215.0M	-639.0M	-445.0M
Pre-tax Income i	488.0M	-1.2B	-72.0M	-571.0M	-677.0M
Income Tax i	150.0M	36.0M	6.0M	-88.0M	-103.0M
Effective Tax Rate % i	30.7%	0.0%	0.0%	0.0%	0.0%
Net Income i	338.0M	-1.2B	-78.0M	-483.0M	-574.0M
Net Margin % i	7.6%	-27.9%	-1.8%	-10.1%	-17.5%
Key Metrics
EBITDA i	895.0M	945.0M	1.0B	1.0B	613.0M
EPS (Basic) i	$0.68	$-2.50	$-0.15	$-0.97	$-1.27
EPS (Diluted) i	$0.68	$-2.50	$-0.15	$-0.97	$-1.27
Basic Shares Outstanding i	494000000	492300000	488300000	487200000	441400000
Diluted Shares Outstanding i	494000000	492300000	488300000	487200000	441400000

Income Statement Trend

Elanco Animal Health Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets
Cash & Equivalents i	468.0M	352.0M	345.0M	638.0M	495.0M
Short-term Investments i	-	-	-	-	-
Accounts Receivable i	805.0M	842.0M	797.0M	833.0M	872.0M
Inventory i	1.6B	1.7B	1.5B	1.4B	1.6B
Other Current Assets	287.0M	310.0M	394.0M	237.0M	256.0M
Total Current Assets i	3.2B	3.4B	3.3B	3.3B	3.4B
Non-Current Assets
Property, Plant & Equipment i	990.0M	985.0M	941.0M	1.4B	1.4B
Goodwill i	12.5B	14.7B	16.8B	17.9B	18.8B
Intangible Assets i	3.7B	4.5B	4.8B	5.6B	6.4B
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	311.0M	341.0M	378.0M	390.0M	348.0M
Total Non-Current Assets i	9.4B	11.0B	12.2B	13.2B	14.3B
Total Assets i	12.6B	14.4B	15.5B	16.5B	17.7B
Liabilities
Current Liabilities
Accounts Payable i	296.0M	270.0M	390.0M	416.0M	501.0M
Short-term Debt i	44.0M	38.0M	388.0M	294.0M	555.0M
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	466.0M	409.0M	454.0M	433.0M	582.0M
Total Current Liabilities i	1.3B	1.2B	1.7B	1.6B	2.1B
Non-Current Liabilities
Long-term Debt i	4.3B	5.7B	5.4B	6.0B	5.6B
Deferred Tax Liabilities i	449.0M	567.0M	662.0M	765.0M	900.0M
Other Non-Current Liabilities	302.0M	411.0M	229.0M	262.0M	322.0M
Total Non-Current Liabilities i	5.2B	6.9B	6.5B	7.3B	7.1B
Total Liabilities i	6.5B	8.1B	8.2B	9.0B	9.2B
Equity
Common Stock i	0	0	0	0	0
Retained Earnings i	-2.0B	-2.3B	-1.1B	-979.0M	-477.0M
Treasury Stock i	-	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	6.1B	6.2B	7.3B	7.5B	8.5B
Key Metrics
Total Debt i	4.3B	5.8B	5.8B	6.3B	6.1B
Working Capital i	1.9B	2.2B	1.6B	1.6B	1.3B

Balance Sheet Composition

Elanco Animal Health Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income i	338.0M	-1.2B	-78.0M	-483.0M	-574.0M
Depreciation & Amortization i	662.0M	694.0M	682.0M	716.0M	517.0M
Stock-Based Compensation i	55.0M	46.0M	59.0M	66.0M	47.0M
Working Capital Changes i	149.0M	-300.0M	-462.0M	-88.0M	46.1M
Operating Cash Flow i	1.1B	-803.0M	351.0M	138.0M	29.1M
Investing Activities
Capital Expenditures i	-147.0M	-140.0M	-171.0M	-159.0M	-63.0M
Acquisitions i	1.3B	-19.0M	0	-342.0M	-4.6B
Investment Purchases i	-	-	-	-	-
Investment Sales i	-	-	-	-	32.7M
Investing Cash Flow i	1.2B	-155.0M	-166.0M	-492.0M	-4.6B
Financing Activities
Share Repurchases i	-	-	-	-	-
Dividends Paid i	-	-	-	-	-
Debt Issuance i	570.0M	600.0M	988.0M	1.0B	4.8B
Debt Repayment i	-2.0B	-677.0M	-1.5B	-823.0M	-952.0M
Financing Cash Flow i	-1.5B	-83.0M	-799.0M	460.0M	5.0B
Free Cash Flow i	380.0M	117.0M	268.0M	286.0M	-352.0M
Net Change in Cash i	780.0M	-1.0B	-614.0M	106.0M	412.8M

Cash Flow Trend

Elanco Animal Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 22.28

Forward P/E 20.86

Price to Book 1.44

Price to Sales 2.17

PEG Ratio -0.19

Profitability Ratios

Profit Margin 9.68%

Operating Margin 6.85%

Return on Equity 6.83%

Return on Assets 0.98%

Financial Health

Current Ratio 2.60

Debt to Equity 62.13

Beta 1.62

Per Share Data

EPS (TTM) $0.88

Book Value per Share $13.64

Revenue per Share $9.06

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
elan	9.7B	22.28	1.44	6.83%	9.68%	62.13
Haleon Plc - ADR	41.7B	19.93	5.08	9.38%	13.81%	53.41
United Therapeutics	19.3B	16.92	2.68	19.30%	40.36%	0.00
Regencell Bioscience	7.6B	-1,779.13	1,121.43	-47.77%	0.00%	0.00
Alkermes plc	5.3B	13.50	3.11	23.94%	23.15%	4.47
Prestige Consumer	3.8B	17.92	2.07	12.30%	18.86%	56.91

Financial data is updated regularly. All figures are in the company's reporting currency.